Heritage Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.03M | Buy |
3,291
+530
| +19% | +$537K | 0.3% | 88 |
|
|
2025
Q4 | $2.97M | Sell |
2,761
-330
| -11% | -$316K | 0.3% | 83 |
|
|
2025
Q3 | $2.36M | Sell |
3,091
-83
| -3% | -$61.8K | 0.25% | 94 |
|
|
2025
Q2 | $2.47M | Buy |
3,174
+151
| +5% | +$117K | 0.29% | 87 |
|
|
2025
Q1 | $2.5M | Buy |
3,023
+472
| +19% | +$393K | 0.3% | 86 |
|
|
2024
Q4 | $1.97M | Buy |
+2,551
| New | +$2.11M | 0.23% | 105 |
|
|
2024
Q2 | $2.27M | Buy |
2,503
+91
| +4% | +$72.8K | 0.3% | 92 |
|
|
2024
Q1 | $1.88M | Sell |
2,412
-78
| -3% | -$55.5K | 0.25% | 102 |
|
|
2023
Q4 | $1.45M | Buy |
2,490
+225
| +10% | +$131K | 0.2% | 117 |
|
|
2023
Q3 | $1.22M | Buy |
2,265
+537
| +31% | +$277K | 0.19% | 119 |
|
|
2023
Q2 | $810K | Buy |
+1,728
| New | +$725K | 0.12% | 146 |
|
|
2023
Q1 | – | Sell |
-2,099
| Closed | -$768K | – | 242 |
|
|
2022
Q4 | $768K | Buy |
2,099
+498
| +31% | +$177K | 0.13% | 146 |
|
|
2022
Q3 | $518K | Sell |
1,601
-19
| -1% | -$6.02K | 0.09% | 172 |
|
|
2022
Q2 | $525K | Buy |
1,620
+5
| +0.3% | +$1.5K | 0.09% | 180 |
|
|
2022
Q1 | $462K | Buy |
1,615
+14
| +0.9% | +$3.6K | 0.07% | 188 |
|
|
2021
Q4 | $442K | Hold |
1,601
| – | – | 0.06% | 193 |
|
|
2021
Q3 | $370K | Sell |
1,601
-10
| -0.6% | -$2.47K | 0.05% | 199 |
|
|
2021
Q2 | $369K | Buy |
1,611
+10
| +0.6% | +$2.01K | 0.05% | 198 |
|
|
2021
Q1 | $299K | Hold |
1,601
| – | – | 0.05% | 204 |
|
|
2020
Q4 | $270K | Hold |
1,601
| – | – | 0.04% | 197 |
|
|
2020
Q3 | $237K | Hold |
1,601
| – | – | 0.04% | 190 |
|
|
2020
Q2 | $263K | Sell |
1,601
-30
| -2% | -$4.61K | 0.05% | 181 |
|
|
2020
Q1 | $226K | Hold |
1,631
| – | – | 0.06% | 166 |
|
|
2019
Q4 | $214K | Buy |
+1,631
| New | +$189K | 0.04% | 180 |
|
|
2019
Q2 | – | Sell |
-1,631
| Closed | -$212K | – | 185 |
|
|
2019
Q1 | $212K | Sell |
1,631
-50
| -3% | -$6.08K | 0.05% | 171 |
|
|
2018
Q4 | $195K | Sell |
1,681
-50
| -3% | -$5.58K | 0.08% | 123 |
|
|
2018
Q3 | $186K | Hold |
1,731
| – | – | 0.07% | 132 |
|
|
2018
Q2 | $148K | Hold |
1,731
| – | – | 0.06% | 137 |
|
|
2018
Q1 | $134K | Hold |
1,731
| – | – | 0.05% | 139 |
|
|
2017
Q4 | $146K | Buy |
1,731
+30
| +2% | +$2.55K | 0.05% | 125 |
|
|
2017
Q3 | $146K | Buy |
1,701
+100
| +6% | +$8.2K | 0.05% | 126 |
|
|
2017
Q2 | $132K | Hold |
1,601
| – | – | 0.05% | 131 |
|
|
2017
Q1 | $135K | Buy |
+1,601
| New | +$128K | 0.05% | 129 |
|
Other funds holding LLY
VCM
VPM
Heritage Trust's LLY Position: Q1 2026 in Review
Heritage Trust increased its Eli Lilly (LLY) stake by 19% in Q1 2026, buying an estimated $537K and bringing the position to 3,291 shares worth $3.03M. The position accounts for 0.3% of the portfolio, ranked #88.
Heritage Trust first reported a position in LLY in Q1 2017 and has held it in 33 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Heritage Trust held 3,291 shares of Eli Lilly worth $3.03M as of Q1 2026.
- Heritage Trust bought 530 Eli Lilly shares in Q1 2026, an estimated $537K.
- Eli Lilly made up 0.3% of Heritage Trust's portfolio in Q1 2026, its #88 holding.
- Heritage Trust first reported a position in Eli Lilly in Q1 2017 and has held it in 33 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Heritage Trust's 13F filing for Q1 2026, filed 13 May 2026.